Recently, Li et al. (2020) revealed that patients with PD with EPVS in the substantia nigra (SN) showed greater expression of tau protein in CSF and a trend toward reduced DAT binding than those without SN-EPVS. This evidence concerns the gene MAPT and Parkinson disease.